Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study

  • Rebekka Lencer
  • , Andreas Sprenger
  • , James L. Reilly
  • , Jennifer E. McDowell
  • , Leah H. Rubin
  • , Judith A. Badner
  • , Matcheri S. Keshavan
  • , Godfrey D. Pearlson
  • , Carol A. Tamminga
  • , Elliot S. Gershon
  • , Brett A. Clementz
  • , John A. Sweeney*
  • *Korrespondierende/r Autor/-in für diese Arbeit
  • Warren Wright Adolescent Center
  • Northwestern University
  • Department of Psychology
  • University of Georgia
  • University of Illinois at Chicago
  • University of Chicago
  • Harvard University
  • Institute of Living/Hartford Hospital
  • Department of Neurobiology
  • University of Texas Southwestern

Abstract

Smooth pursuit eye tracking deficits are a promising intermediate phenotype for schizophrenia and possibly for psychotic disorders more broadly. The Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium investigated the severity and familiality of different pursuit parameters across psychotic disorders. Probands with schizophrenia (N=265), schizoaffective disorder (N=178), psychotic bipolar disorder (N=231), their first-degree relatives (N=306, N=217, N=273, respectively) and healthy controls (N=305) performed pursuit tracking tasks designed to evaluate sensorimotor and cognitive/predictive aspects of pursuit. Probands from all diagnostic groups were impaired on all pursuit measures of interest compared to controls (p<0.001). Schizophrenia probands were more impaired than other proband groups on both early pursuit gain and predictive gain. Relatives with and without enhanced psychosis spectrum personality traits were impaired on initial eye acceleration, the most direct sensorimotor pursuit measure, but not on pursuit gain measures. This suggests that alterations in early sensorimotor function may track susceptibility to psychosis even in the absence of psychosis related personality traits. There were no differences in pursuit measures between relatives of the three proband groups. Familiality estimates of pursuit deficits indicate that early pursuit gain was more familial than predictive gain, which has been the most widely used measure in previous family studies of psychotic disorders. Thus, while disease-related factors may induce significant impairments of pursuit gain, especially in schizophrenia, the pattern of deficits in relatives and their familiality estimates suggest that alterations in sensorimotor function at pursuit onset may indicate increased susceptibility across psychotic disorders.

OriginalspracheEnglisch
ZeitschriftSchizophrenia Research
Jahrgang169
Ausgabenummer1-3
Seiten (von - bis)326-333
Seitenumfang8
ISSN0920-9964
DOIs
PublikationsstatusVeröffentlicht - 01.12.2015

Fördermittel

This work was supported by the National Institute of Mental Health [grant numbers: MH077851 (CAT), MH078113 (MSK), MH077945 (GDP), MH077852 (GKT) and MH077862 (JAS)]. The NIMH has no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or the decision to submit the manuscript for publication. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number TL1TR001104 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. All authors have declared no conflicts of interest in relation to the subject of this study. Rebekka Lencer, James L. Reilly, Andreas Sprenger, Jennifer E. McDowell, Brett A. Clementz, and Godfrey D. Pearlson report no biomedical financial interests or potential conflicts of interest. Matcheri S. Keshavan reports the following financial disclosure: Sunovion. John A. Sweeney reports the following financial disclosures: Eli Lilly Pharmaceuticals — Ad Hoc Consultant, F. Hoffmann-La Roche, Ltd. — Ad Hoc Consultant. Carol A. Tamminga reports the following financial disclosures: American Psychiatric Association — Deputy Editor; Astellas — Ad Hoc Consultant; Autifony — Ad Hoc Consultant; The Brain and Behavior Foundation — Council Member; Eli Lilly Pharmaceuticals — Ad Hoc Consultant; Intra-cellular Therapies (ITI, Inc.) — Advisory Board, drug development; Institute of Medicine — Council Member; National Academy of Medicine — Council Member; Pfizer — Ad Hoc Consultant; Sunovion — Investigator Initiated grant funding.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Fingerprint

Untersuchen Sie die Forschungsthemen von „Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren